Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech crawled time : 13:15 save search
Moleculin Biotech, Inc to Present at the Virtual Investor Roundtable Event
Published: 2021-11-12 (Crawled : 13:15) - prnewswire.com
MBRX | $4.45 -4.3% -4.49% 17K
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: 0.0%
biotech iot
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 to Achieve a Functional Cure for Chronic Hepatitis B Virus (HBV) Infection at AASLD The Liver Meeting®
Published: 2021-11-12 (Crawled : 13:15) - globenewswire.com
VIR | $8.11 2.01% 1.97% 1.1M
|
Health Technology
|
| O: 4.66%
H: 0.0%
C: 0.0%
ALNY | $145.78 0.95% 0.94% 390K
|
Health Technology
|
| O: -2.06%
H: 0.0%
C: 0.0%
hepatitis potential biotech technology iot liver injection infections chronic hepatitis b
Biotech Acquisition Company and Blade Therapeutics Announce Definitive Merger Agreement
Published: 2021-11-08 (Crawled : 13:15) - prnewswire.com
BIOT | $10.15 -0.78% -0.2% 44K
|
|
| O: 0.82%
H: 0.41%
C: 0.0%
acquisition merger agreement biotech iot merge therapeutics
Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs
Published: 2021-10-19 (Crawled : 13:15) - globenewswire.com
SANA | $7.96 4.6% 4.4% 2.1M
|
|
| O: 0.84%
H: 3.42%
C: -2.35%
BEAM | $24.13 0.96% 0.95% 2.1M
|
Health Technology
|
| O: 2.35%
H: 3.8%
C: 1.63%
crispr biotech license technology iot
Brickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Primary and Secondary Endpoints, from Both U.S. Phase 3 Pivotal Clinical Studies of Sofpironium Bromide Gel, 15% in Primary Axillary Hyperhidrosis Patients
Published: 2021-10-07 (Crawled : 13:15) - globenewswire.com
BBI | $2.12 16.04%
|
Health Technology
|
| O: 13.26%
H: 1.2%
C: -16.0%
positive results topline biotech phase 3 iot
PDS Biotechnology Welcomes Matthew Hill as Chief Financial Officer
Published: 2021-10-06 (Crawled : 13:15) - globenewswire.com
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: -0.58%
H: 1.25%
C: 0.77%
SSKN | $0.569 4.4% 4.22% 9.3K
|
Health Technology
|
| O: -0.53%
H: 1.06%
C: 0.53%
PDSB | $2.99 13.04% 11.54% 680K
|
Health Technology
|
| O: -2.58%
H: 2.5%
C: -1.65%
biotech technology iot
BioCardia Announces Participation at the A.G.P. Biotech & Specialty Pharma Conference October 13, 2021 (Virtual Conference)
Published: 2021-10-06 (Crawled : 13:15) - globenewswire.com
BCDA P | $0.351 -2.5% -2.56% 51K
|
Health Technology
|
| O: -1.06%
H: 1.72%
C: 0.0%
biotech iot conference pharma
Acurx Pharmaceuticals to Participate in the A.G.P. Biotech and Specialty Pharma Conference October 13, 2021
Published: 2021-09-29 (Crawled : 13:15) - biospace.com/
ACXP | $1.965 -2.24% -2.29% 52K
|
Professional, Scientific, and T...
|
| O: -1.88%
H: 15.35%
C: 11.3%
biotech iot conference pharma
PDS Biotechnology to Present at the Benzinga Healthcare Conference
Published: 2021-09-27 (Crawled : 13:15) - globenewswire.com
PDSB | $2.99 13.04% 11.54% 680K
|
Health Technology
|
| O: -0.66%
H: 4.01%
C: -0.43%
biotech technology iot conference presentation
Oncolytics Biotech® Announces Preclinical Data Demonstrating the Synergistic Immunotherapeutic Effects of Pelareorep Combined with Radiotherapy
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.52%
H: 9.63%
C: 3.06%
therapy biotech iot preclinical pre-clinical
PDS Biotech Achieves Safety Requirement Milestone For the First 12 Patients in the VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Advanced Head and Neck Cancer
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
PDSB | $2.99 13.04% 11.54% 680K
|
Health Technology
|
| O: -3.22%
H: 6.02%
C: 2.15%
phase 2 cancer biotech iot trial keytruda milestone
INmune Bio, Inc. to Present at the BTIG Virtual Biotechnology Conference
Published: 2021-08-05 (Crawled : 13:15) - biospace.com/
INMB | News 0 d | $10.615 26.82% 21.15% 680K
|
Health Technology
|
| O: -1.77%
H: 8.36%
C: 7.71%
biotech technology iot conference
OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference
Published: 2021-07-26 (Crawled : 13:15) - biospace.com/
ONCS | $0.2772 25.59% 52M
|
Health Services
|
| O: -3.59%
H: 6.51%
C: 3.26%
biotech technology iot conference
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
Published: 2021-07-08 (Crawled : 13:15) - biospace.com/
ALRN | $4.8 1.27% 1.25% 110K
|
Health Technology
|
| O: -2.61%
H: 4.46%
C: -0.89%
biotech iot conference
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement
Published: 2021-06-02 (Crawled : 13:15) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.42%
H: 0.15%
C: -0.78%
LGND | $68.58 -5.37% -5.67% 250K
|
Health Technology
|
| O: 0.82%
H: 1.37%
C: -1.0%
biotech iot license
MAIA Biotechnology, Inc. Raises $8.0 Million Financing to Advance Pipeline of Targeted Immuno-Oncology Studies
Published: 2021-05-19 (Crawled : 13:15) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.75%
H: 0.21%
C: -0.41%
biotech technology iot
PDS Biotechnology Appoints Immuno-Oncology Experts Dr. Olivera Finn and Dr. Mark Frohlich to Scientific Advisory Board
Published: 2021-05-18 (Crawled : 13:15) - biospace.com/
PDSB | $2.99 13.04% 11.54% 680K
|
Health Technology
|
| O: 0.41%
H: 14.6%
C: 13.39%
biotech technology iot liver
CymaBay Welcomes Dennis D. Kim, MD, MBA as Chief Medical OfficerExperienced Biotech Executive, Physician-Scientist and Orphan Disease Expert to Lead Clinical/Medical Functions as Seladelpar Advances in Phase 3 and as Pipeline Programs Mature
Published: 2021-05-13 (Crawled : 13:15) - biospace.com/
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: -1.72%
H: 2.7%
C: -2.4%
disease biotech phase 3 iot
Brickell Biotech to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13, 2021
Published: 2021-04-29 (Crawled : 13:15) - globenewswire.com
BBI | $2.12 16.04%
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: -3.67%
financial results results biotech iot
Sana Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2021
Published: 2021-04-09 (Crawled : 13:15) - globenewswire.com
SANA | $7.96 4.6% 4.4% 2.1M
|
|
| O: -0.34%
H: 0.0%
C: -2.03%
cancer biotech research technology iot preclinical pre-clinical
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.